Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM)

ConclusionsPatients who receive neoadjuvant chemotherapy for liver metastasis surgery have a greater splenic volume increase, which correlates with NAFLD and a lower survival.

http://link.springer.com/10.1007/s12094-019-02245-1

Source: Clinical and Translational Oncology - May 30, 2020 Category: Cancer & Oncology Source Type: research